首页> Journal of affective disorders> Patterns of use, clinical efficacy, safety and tolerability of Ketamine and Esketamine in treatment-resistant depression: Towards registry‐based surveillance systems

Patterns of use, clinical efficacy, safety and tolerability of Ketamine and Esketamine in treatment-resistant depression: Towards registry‐based surveillance systems

导出原文传递

翻译打印收藏纠错

第一作者： Lopez-Diaz A.

作者： Lopez-Diaz A. ^[1] ; Rendon de Lope L. ^[2] ; de la Vega Sanchez D.

作者单位： UGC Salud Mental Hospital Universitario Virgen Macarena ^[1] UGC Farmacia Hospitalaria Hospital Universitario Virgen Macarena ^[2]

关键词 Depression Esketamine Ketamine Treatment-resistant depression

发布时间 2022-03-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

Journal of affective disorders

2022年297卷

145-147页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览2

Journal of affective disorders

2022年297卷

145-147页

检索历史清除

Patterns of use, clinical efficacy, safety and tolerability of Ketamine and Esketamine in treatment-resistant depression: Towards registry‐based surveillance systems

Journal of affective disorders

相似文献

同项目论文

Journal of affective disorders

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Patterns of use, clinical efficacy, safety and tolerability of Ketamine and Esketamine in treatment-resistant depression: Towards registry‐based surveillance systems

Journal of affective disorders

相似文献

同项目论文

Journal of affective disorders

相关期刊

检索历史清除